Department of Immunology and Inflammation

First-in-class drug candidate for multiple myeloma shows promise in Phase 1 trial A multiple myeloma candidate with a new mode of action is now in Phase 2 patient trials following positive Phase 1 results showing it kills cancer ce...

A multiple myeloma candidate, DTP3, with a new mode of action, is now in Phase 2 trials after positive Phase 1 results showed it kills cancer cells without toxicity to patients.

Prof. Guido Franzoso and his team developed the first in-class drug.👇
www.imperial.ac.uk/news/article...

YouTube video by Imperial College London Come for a lab tour with PhD student Sophie to explore the Centre of Myeloma Research 🔬🥼🧫

Curious about the work happening in our Centre of Myeloma Research?

Join Sophie Ball for a behind‑the‑scenes look at the lab and hear what life is really like as a PhD student.

Watch now👇
youtube.com/shorts/WBRrY...

Developing machine learning methods to infer the evolution of haematological cancers at Imperial College London on FindAPhD.com PhD Project - Developing machine learning methods to infer the evolution of haematological cancers at Imperial College London, listed on FindAPhD.com

If you’re interested in machine learning and mathematical modelling, we’re recruiting a PhD student to develop new methods for studying cancer evolution at
@imperialimmuno.bsky.social

www.findaphd.com/phds/project...

We're #hiring for new non‑clinical Assistant Professors!

Keen to join us at the Department of Immunology and Inflammation?

Make sure to select ‘Immunology and Inflammation’ as your first preference when applying.

✍️Apply by 11 March 2026.

👉 www.imperial.ac.uk/jobs/search-...

Platinum success for four Green Impact teams Imperial held its annual awards ceremony to celebrate the efforts of its Green Impact teams who engaged over 2,500 staff and students in sustainabili...

Congratulations to our Centre for Haematology and Centre for Inflammatory Disease for earning Silver in the Green Impact awards! 🌍🏆

Over 2,500 staff and students engaged in sustainability efforts this year through the Green Impact awards.👇
www.imperial.ac.uk/news/article...

Long Covid and ME patients 'hopeful' about Rosetta Stone study The £1.1m Rosetta Stone study hopes to make a breakthrough by comparing both conditions.

"We're hoping that our work will make clearer the underlying mechanisms and inform further clinical trials."

Prof Danny Altmann comments in BBC News on a new Rossetta Stone study, which hopes to look for biomarkers for ME/CFS.👇
www.bbc.co.uk/news/article...

Celebrating Professor Barbara Bain: A Life in Haematology and Education Celebrating Professor Barbara Bain: A Life in Haematology and Education

“I’ve always been keen on teaching because if you see something interesting or discover something unusual, you want to share it.”

We celebrate Professor Emerita Barbara Bain, who has spent five decades shaping haematology and medical education. Read more👇
www.imperial.ac.uk/news/article...

Chronic fatigue syndrome seems to have a very strong genetic element The largest study so far into the genetics of chronic fatigue syndrome, or myalgic encephalomyelitis, has implicated 259 genes – six times more than those identified just four months ago

ME/CFS has a strong genetic basis. 🧬

Largest study yet links the condition to 259 genes – 6x more than previously identified.

@imperialimmuno.bsky.social's Prof Danny Altmann says we’re at a “coming of age” in understanding a condition long neglected 👇 www.newscientist.com/article/2508... #MECFS

2025 MSc Immunology students attending the BSI Conference in Liverpool

We're glad to see our MSc Immunology students at the @britsocimm.bsky.social conference earlier this month!

Our master's students get an opportunity to immerse themselves in real-world research and conference culture as part of the programme.

👉 www.imperial.ac.uk/study/course...

IMAGE DESCRIPTION: Photo if a scientist holding blood vials. Photo of Professor Danny Altman. Heading - The ME Association is finding Imperial College London scientists in £1.1m ground-breaking research study. Imperial, Ramsay Research Fund, and ME Association logos.

IMAGE DESCRIPTION: Small photo of someone getting a blood test. Wording - The ME Association is investing £1.1m into the Rosetta Stone study - the largest ever single investment in biomedical research by any charity in this field, and the largest research project of its kind. Arrow indicating to slide to the next picture

IMAGE DESCRIPTION: Small photo of someone having a saliva swab. Wording - Top scientists at Imperial College London will lead the three-year Rosetta Stone study, conducting side-by-side cellular and molecular analyses of ME/CFS and Long Covid. Arrow indication you should slide to the right to the next picture.

IMAGE DESCRIPTION: Small photo of people wording in a lab. Wording - This will offer an unprecedented look into what these conditions share, which may take us closer to diagnostic biomarkers and treatment pathways. Arrow indicating you should slide right.

1/2: Driving discovery: The ME Association invests £1.1m into pioneering research programme!

We are incredibly proud to unveil news of our latest investment into ground-breaking research to help world-leading scientists uncover shared pathways between ME/CFS and Long Covid.

#pwME

£1.1m has been awarded by the @meassociation.org.uk to launch Rosetta Stone - a study to uncover shared pathways between ME/CFS and #LongCovid.

The study will be the largest of its kind and pave the way for better treatments.👇
www.imperial.ac.uk/news/article...

Investigating impact of bone marrow inflammation on haematopoiesis in Diamond-Blackfan anaemia syndrome at Imperial College London on FindAPhD.com PhD Project - Investigating impact of bone marrow inflammation on haematopoiesis in Diamond-Blackfan anaemia syndrome at Imperial College London, listed on FindAPhD.com

🚨 PhD Opportunity at @imperialimmuno.bsky.social!

Join Dr Deena Iskander’s lab to explore how bone marrow inflammation affects haematopoiesis in Diamond-Blackfan anaemia.

📍Hammersmith Campus
💰£22,780/year + Home Tuition

Apply now👇
www.findaphd.com/phds/project...

Description Please note that job descriptions are not exhaustive, and you may be asked to take on additional duties that align with the key responsibilities ment...

🚨We're hiring!

Join us as an Assistant / Associate / Chair (Professor) in Inflammation at our Hammersmith Campus. #AcademicJobs #Immunology

🔬 World-class research
📚 Supportive academic environment
💼 Competitive salary & benefits

Apply by 10 Dec👇
www.imperial.ac.uk/jobs/search-...

The research, funded by @cancerresearchuk.org and Children with Cancer UK, was in partnership with @ox.ac.uk and @uofglasgow.bsky.social.

Read the paper in @bloodjournals.hematology.org.👇
ashpublications.org/blood/articl...

Modified CAR-iNKT therapy more effective in childhood leukaemia treatment | Imperial News | Imperial College London Scientists found that using two targets in CAR-iNKT therapy in mice can outperform standard treatments for high-risk childhood leukaemia.

A modified CAR-iNKT therapy that targets two markers (CD19 + CD133) eliminated a high-risk childhood leukaemia in mice, outperforming standard CAR-T therapy. 💉

This is a step toward more efficient treatments for children with leukaemia.👇
www.imperial.ac.uk/news/268073/...

Join us on 18 Sept for our Patient & Public Engagement Event on acute leukaemia.

💬 Talks & roundtable discussions on ALL, MDS & AML
📌Hammersmith Hospital Campus

Sponsored by @bloodcanceruk.bsky.social.

Find out more 👉 imperial.ac.uk/events/197770/engagement-event-on-acute-laeukaemia/

Imperial recognised for leadership around openness on animal research | Imperial News | Imperial College London Imperial College London has been awarded Leader in Openness status by Understanding Animal Research for the third time, for 2025-2028.

"Animal research forms a small but vital part of Imperial's world-leading biomedical research as we seek new ways to benefit human health."

Prof Marina Botto responds to Imperial's Leader in Openness status from @animalresearch.bsky.social.👇
www.imperial.ac.uk/news/264033/...

The lung B cell response also generated memory B cells in the lung, suggesting the response "may be relevant to vaccine strategies aimed at generating local immunity, such as respiratory infections" according to our Dr Alice Denton, Senior Lecturer.

Researchers from the @babrahaminst.bsky.social and Imperial have found that the lungs can generate good-quality B cell responses.

They administered an inflammatory agent to mice through the nose and observed their immune response in the lungs.

Read in @pnas.org👇
www.pnas.org/doi/10.1073/...

Congratulations to our Dr Sophie Rutschmann for recieving the Established Educator Teaching Excellence Award. 🥳

Sophie leads our MSc Immunology course and evolves the program to keep its curriculum relevant and ensure it provides a solid training for the immunologists of the future.

Personalising risk from COVID-19 key to protecting immunosuppressed people | Imperial News | Imperial College London New research underscores the need for ongoing COVID-19 protection for people with weakened immune systems.

A simple blood test could transform #COVID19 care for immunosuppressed people🩸

The MELODY study has revealed how personalised approaches to #vaccination could protect those most at risk.

Read more ⤵️
imperial.ac.uk/news/260173/...

New study paves way for immunotherapies tailored for childhood cancers | Imperial News | Imperial College London New research shows how children’s immune systems react differently to cancer than adult immune systems.

New research shows how children’s immune systems react differently to cancer than adult immune systems.

Prof Petter Brodin @petterbrodin.bsky.social led the research while at the @karolinskainst.bsky.social.👇
www.imperial.ac.uk/news/260116/...

An image of Professor Julie Makani, Muhmbilli University of Allied Sciences and Imperial College London next to the title of '50 scientists that Inspire'. The quote reads "Whichever field you're in, remember that you are making a difference, whether or not you can see it in front of you."

"I stay in science because I see it as a way of improving health and having an impact."

Read Prof Julie Makani's (@juliemakani.bsky.social) profile in
@cellpress.bsky.social 50 scientists that inspire.

👉 cell.com/news-do/50-i...

Sickle Cell Alliance formed to accelerate innovation and investment in research The Alliance combines the expertise of clinicians, researchers, educators and patient advocates.

A Sickle Cell Alliance by Imperial College Healthcare NHS Trust and @imperialcollegeldn.bsky.social aims to improve the lives of patients with sickle cell disease.

The alliance combines the expertise of clinicians, researchers, educators and patient advocates.

👉 imperial.nhs.uk/about-us/new...

Mary Adeturinmo: Combining science and creativity - Imperial people Celebrating Disability History Month “Raising awareness about living with Sickle Cell can help others facing similar challenges and demonstrate that it is possible to thrive in science while living wi...

“Raising awareness about living with Sickle Cell can help others facing similar challenges and demonstrate that it is possible to thrive in science.”

Mary Adeturinmo speaks about living with Sickle Cell Disease for disability history month.👇
blogs.imperial.ac.uk/imperial-peo...